Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
383.52
-4.54 (-1.16%)
Feb 21, 2025, 10:16 AM EST - Market open
Elevance Health Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Elevance Health stock have an average target of 530.83, with a low estimate of 405.4 and a high estimate of 649. The average target predicts an increase of 38.41% from the current stock price of 383.52.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elevance Health stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Hold Reiterates $405 | Hold | Reiterates | $405 | +5.71% | Jan 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $483 → $478 | Buy | Maintains | $483 → $478 | +24.63% | Jan 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $485 | Buy | Reiterates | $485 | +26.46% | Jan 24, 2025 |
| Barclays | Barclays | Buy Maintains $501 → $512 | Buy | Maintains | $501 → $512 | +33.50% | Jan 24, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $520 → $480 | Strong Buy | Maintains | $520 → $480 | +25.16% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
194.71B
Revenue Next Year
208.89B
from 194.71B
Increased by 7.28%
EPS This Year
34.49
from 25.68
Increased by 34.33%
EPS Next Year
39.44
from 34.49
Increased by 14.36%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 213.9B | 231.4B | 252.3B |
| Avg | 194.7B | 208.9B | 228.8B |
| Low | 179.1B | 192.2B | 211.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 18.8% | 20.8% |
| Avg | - | 7.3% | 9.5% |
| Low | - | -1.3% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.54 | 43.68 | 50.66 | ||
| Avg | 34.49 | 39.44 | 46.37 | ||
| Low | 30.32 | 34.59 | 42.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 42.3% | 26.6% | 28.4% | ||
| Avg | 34.3% | 14.4% | 17.6% | ||
| Low | 18.1% | 0.3% | 7.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.